Business Description

Goldenwell Biotech Inc
NAICS : 446191 SIC : 5142
ISIN : US38138N1046

Share Class Description:

GWLL: Ordinary Shares
Description
Goldenwell Biotech Inc is engaged in the research and development, production, and sales of health care and supplements products. Its products comprise JI MAI - Bovine Cardiac Vascular Active Peptide, Double Proline AG - 3D Active Collagen Peptide, Cartilage Peptide - Type II collagen peptide, and Sugar Master.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.37
Interest Coverage No Debt
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 16.31
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Book Growth Rate -30.7

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -76.56
12-1 Month Momentum % -80.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 228
Quick Ratio 53
Cash Ratio 53
Days Sales Outstanding 365

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -11700
Net Margin % -11700
FCF Margin % -11500
ROE % -83.33
ROA % -54.47
ROIC % -64.86
ROC (Joel Greenblatt) % -65.29
ROCE % -56.09

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio N/A
N/A
N/A
PE Ratio without NRI N/A
N/A
N/A
PB Ratio 58.6
EV-to-EBIT -49.41
EV-to-EBITDA -49.41
EV-to-Revenue 5781
EV-to-FCF -50.27
Earnings Yield (Greenblatt) % -2.02
FCF Yield % -1.98

Financials

GWLL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:GWLL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Goldenwell Biotech Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.001
EPS (TTM) ($) 0
Beta 0
Volatility % 76.69
14-Day RSI 0
14-Day ATR ($) 0.000015
20-Day SMA ($) 0.0586
12-1 Month Momentum % -80.14
52-Week Range ($) 0.0586 - 0.295
Shares Outstanding (Mil) 99

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Goldenwell Biotech Inc Filings

Filing Date Document Date Form
No Filing Data

Goldenwell Biotech Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Goldenwell Biotech Inc Frequently Asked Questions

What is Goldenwell Biotech Inc(GWLL)'s stock price today?
The current price of GWLL is $0.06. The 52 week high of GWLL is $0.30 and 52 week low is $0.06.
When is next earnings date of Goldenwell Biotech Inc(GWLL)?
The next earnings date of Goldenwell Biotech Inc(GWLL) is .
Does Goldenwell Biotech Inc(GWLL) pay dividends? If so, how much?
Goldenwell Biotech Inc(GWLL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1